CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD147 and MCT1-potential partners in bladder cancer aggressiveness and cisplatin resistance
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume 54, Issue 11, Pages 1451-1466
Publisher
Wiley
Online
2014-09-28
DOI
10.1002/mc.22222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer
- (2014) Rosário Pinto-Leite et al. TUMOR BIOLOGY
- Recent advances in the diagnosis and treatment of bladder cancer
- (2013) Grace Cheung et al. BMC Medicine
- The SLC16 gene family – Structure, role and regulation in health and disease
- (2013) Andrew P. Halestrap MOLECULAR ASPECTS OF MEDICINE
- The Tumor Microenvironment: A Pitch for Multiple Players
- (2013) Giovanna Schiavoni et al. Frontiers in Oncology
- Everolimus combined with cisplatin has a potential role in treatment of urothelial bladder cancer
- (2012) Rosário Pinto-Leite et al. BIOMEDICINE & PHARMACOTHERAPY
- ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings
- (2012) Cora N. Sternberg et al. EUROPEAN UROLOGY
- Role of monocarboxylate transporters in human cancers: state of the art
- (2012) Céline Pinheiro et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma
- (2012) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of CD44 in tumour progression and strategies for targeting
- (2012) Lalit Mohan Negi et al. JOURNAL OF DRUG TARGETING
- Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets
- (2012) Vera Miranda-Gonçalves et al. NEURO-ONCOLOGY
- The Warburg effect: Insights from the past decade
- (2012) Mohita Upadhyay et al. PHARMACOLOGY & THERAPEUTICS
- CD44s and CD44v6 in Diagnosis and Prognosis of Human Bladder Cancer
- (2012) Ola M. Omran et al. ULTRASTRUCTURAL PATHOLOGY
- Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer
- (2011) Nelma Pértega-Gomes et al. BMC CANCER
- CD147 overexpression allows an accurate discrimination of bladder cancer patients’ prognosis
- (2011) J. Afonso et al. EJSO
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Reduction of Hyaluronan-CD44–Mediated Growth, Migration, and Cisplatin Resistance in Head and Neck Cancer Due to Inhibition of Rho Kinase and PI-3 Kinase Signaling
- (2010) Carlos Torre et al. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY
- Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis
- (2010) Mario W. Kramer et al. CANCER
- Advances in Platinum Chemotherapeutics
- (2010) Benjamin W. Harper et al. CHEMISTRY-A EUROPEAN JOURNAL
- Hypoxia and energetic tumour metabolism
- (2010) M Christiane Brahimi-Horn et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Expression of Monocarboxylate Transporters 1, 2, and 4 in Human Tumours and Their Association with CD147 and CD44
- (2010) Céline Pinheiro et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro
- (2010) Bo Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CD147 overexpression is a prognostic factor and a potential therapeutic target in bladder cancer
- (2010) Yi-Jun Xue et al. MEDICAL ONCOLOGY
- Carbonic anhydrase IX in bladder cancer
- (2009) Tobias Klatte et al. CANCER
- Hyaluronan, CD44, and Emmprin Regulate Lactate Efflux and Membrane Localization of Monocarboxylate Transporters in Human Breast Carcinoma Cells
- (2009) Mark G. Slomiany et al. CANCER RESEARCH
- Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities
- (2009) B. P. Toole CLINICAL CANCER RESEARCH
- The prognostic value of CD147/EMMPRIN is associated with monocarboxylate transporter 1 co-expression in gastric cancer
- (2009) Céline Pinheiro et al. EUROPEAN JOURNAL OF CANCER
- Hyaluronan, CD44 and Emmprin: Partners in cancer cell chemoresistance
- (2008) Bryan P. Toole et al. DRUG RESISTANCE UPDATES
- Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer
- (2008) Marc Colombel et al. EUROPEAN UROLOGY SUPPLEMENTS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now